Custom Search


Monday 01 March 2004

Ziprasidone: a novel psychotropic with unique properties.

By: Ballas C, Yang C, O'Reardon J, Ballas P, Baldassano C.

Expert Rev Neurother 2004 Mar;4(2):179-86

Ziprasidone (Geodon) is a relatively new atypical antipsychotic medication with a unique pharmacological profile. It is indicated for the treatment of schizophrenia, but has also often been used off-label for other uses. This review summarizes its important properties, specifically the pharmacodynamic parameters, receptor-binding profile and relevance to clinical outcomes, side effects, and potential for drug-drug interactions and established clinical indications. Novel therapeutic applications and relevant clinical trials or reports are also examined. The authors review the current market and speculate on likely changes in 5 years.

Use of this site is subject to the following terms of use